Compound glycyrrhizin plus conventional therapy for psoriasis vulgaris: a systematic review and meta-analysis of randomized controlled trials.

Compound glycyrrhizin plus conventional therapy for psoriasis vulgaris: a systematic review and meta-analysis of randomized controlled trials.
Curr Med Res Opin. 2016 Oct 27;:1-34
Authors: Yu JJ, Zhang CS, Coyle ME, Du Y, Zhang AL, Guo X, Xue CC, Lu C
Abstract
Psoriasis vulgaris is a chronic skin condition affecting patients' quality of life. Long-term use of conventional therapy increases risk of unwanted side effects. Compound Glycyrrhizin in conjunction with conventional therapy has been used in clinical practice, but the evidence of such practice has not been evaluated systematically. This review aims to evaluate efficacy and safety of Compound Glycyrrhizin in combination with conventional therapy for psoriasis vulgaris. PubMed, Excerpta Medica dataBASE (Embase), Cumulative Index to Nursing and Allied Health Literature (CINAHL), Cochrane Central Register of Controlled Trials, Allied and Complementary Medicine Database (AMED), CiNii, Chinese Biomedical Literature, China National Knowledge Infrastructure, Chinese Scientific Journals Full Text Database and Wanfang Data were searched from their respective inceptions to September, 2015. Randomized controlled trials comparing Compound Glycyrrhizin plus conventional therapy to conventional therapy alone for psoriasis vulgaris were included. Data analysis was performed using Review Manager 5.3. Eleven (11) randomized controlled trials were included in this review. Meta-analysis of 11 ran...

Source: Current Medical Research and Opinion - October 28, 2016 Category: Research Tags: Curr Med Res Opin Source Type: research